Antianginal effects of efonidipine hydrochloride, a Ca2+ channel blocker, on angina models in rats, isolated guinea pig hearts and isolated canine arteries

Pharmacometrics

Volumn 53, Issue 2, 1997, Pages 101-108

  Sato, Ryuichi ^a   Jin, Hiromasa ^a   Higashino, Raita ^a   Tanaka, Tsunehisa ^a   Kurimoto, Tadashi ^a   Tamaki, Hajime ^a  

^a ZERIA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Angina pectoris; Ca2+ Channel blocker; Efonidipine hydrochloride; Nifedipine; Nisoldipine

Indexed keywords

ANTIANGINA PECTORIS AGENT; CALCIUM CHANNEL BLOCKING AGENT; EFONIDIPINE; NIFEDIPINE; NISOLDIPINE;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFECT; DRUG SCREENING; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED ARTERY; ISOLATED HEART; NONHUMAN; RAT; ST SEGMENT ELEVATION;

EID: 0030946358     PISSN: 03008533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bean, B.P. (1984): Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state, Proc. Nat. Acad. Sci. USA, 81, 6388-6392.
2. Grover, G.J. and Sleph, P.G. (1989): Dissociation of cardiodepression from cardioprotection with calcium antagonists: Diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine, J. Cardiovasc. Pharmacol., 14, 331-340.
3. Hamm, C.W. and Opie, L.H. (1983): Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart, Circ. Res., 52(supple I), 129-138.
4. Harris, A.S., Bisteni, A., Russel, R.A., Brigham, J.C. and Firestone, J.E. (1954): Excitatory factors in ventricular tachycardia resulting from myocardial ischemia. Potassium a major exitant, Science, 119, 200-203.
5. Hatano, N., Nakatsuji, K., Nose, I. and Shimizu, M. (1980): Effect of Antianginal Agents on Electrocardiographic Change Induced with V asopressin in Rats, Oyo Yakuri/ Pharmacometrics, 19, 311-317.
6. Hiramatsu, Y , Izumi, A., Tezuka, T. and Kurosawa, Y. (1970): Antagonizing substances obtained from whale heart extract to vasopressin induced myocardial hypoxia, Jap. J. Pharmacol., 20, 313-324.
7. Khym, J.K. (1975): An analytical system for rapid separation of tissue nucleotides at low pressure on conventional anion exchangers. Clin. Chem., 21, 1245-1252.
8. Kurihara, S., Hongo, K., Tanaka, T. and Tanaka, E. (1994): Effects of a newly dihydropyridine, NZ-105, on intracellular Ca transient and tension in ferret ventricular muscles, J. Cardiovasc. Pharmacol., 24, 274-280.
9. Masuda, Y., Takeguchi, M., Iwama, T., Sakai, T., Hibi, M., Tanaka, S., Shigenobu, K. and Kasuya, Y. (1990): Anti-hypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative, Arch. Int. Pharmacodyn. Ther., 304, 247-264.
10. Masuda, Y., Iwama, T., Yamashita, T., Sakai, T., Hibi, M., Tanaka, S., Shigenobu, K. and Kasuya, Y. (1991a): Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta, Arch. Int. Pharmacodyn. Ther., 312, 86-103.
11. Masuda, Y., Iwama, T., Yamashita, T., Sakai, T., Hibi, M., Tanaka, S., Shigenobu, K. and Kasuya, Y. (1991b): Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro, Arch. Int. Pharmacodyn. Ther., 314, 57-73.
12. Nakazawa, M., Tamatsu, H., Tsuchihashi, H., Nagatomo, T. and Imai, S. (1985): Beneficial effects of diltiazem on the ischemic derangements of myocardial metabolism assessed by 31P-NMR in the isolated perfused rat heart, Jpn. J. Pharmacol., 39, 51-58.
13. Saida, K., Umeda, M. and Itakura, A. (1994): Improvement of ischemic myocardial dysfunction by nisoldipine, Cardiovasc. Drugs Ther., 2, 365-370.
14. Sakai, K., Akima, M. and Aono, J. (1981): Evaluation of drug effects in a new experimental model of angina pectris in the intact anesthetized rat, J. Pharmacol. Methods, 5, 325-336.
15. Sellevold, O.F.M., Jynge, P. and Aarstad, K. (1986): High performance liquid chromatography: a lapid isocranic method determination of creatine compounds and adenine nucleotides in myocardial tissue, J. Mol. Cell. Cardiol., 18, 517-527.
16. Tamura, T, Saigusa, A. and Kokubun, S. (1991): Mechanisms underlying the slow onset of action of a new dihydropyridine, NZ-105, on a cultured smooth muscle cell line, Naunyn Schmiedeberg's Arch. Pharmacol., 343, 405-410.
17. Uehara, A. and Hume, J.R. (1985): Interactions of organic calcium antagonists with calcium channels in single frog atrial cells, J. Gen. Physiol., 85, 621-647.
18. Umeda, M. and Saida, K. (1993): Improvement of ischemic myocardial dysfunction by nisoldipine in relation to its coronary vasodilating action, Jpn. J. Pharmacol., 62, 1-7.
19. Vergona, R.A., Herrott, C., Garippa, R. and Hirkaler, G. (1984): Mechanisms of methachoine-induced coronary vasospasm in an experimental model of variant angina in the anesthetized rat, Life Sci., 35, 1877-1884.
20. Watts, J.A., Maiorano, L.J. and Maiorano, P.C. (1986): Comparison of the protective effects on verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury, J. Mol. Cell Cardiol., 18, 255-263.
21. Yamashita, T., Masuda, Y., Sakai, T., Tanaka, S. and Kasuya, Y. (1991): NZ-105, a new 1, 4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta, Jpn. J. Pharmacol., 57, 337-348.